Megeno is a Luxembourg-based life sciences company that provides preventive health solutions for individuals, organisations, and healthcare communities.
Our smart, personalised solutions are built upon aggregate, long term healthcare data regarding the biology and lifestyle of the individual. We believe that this aggregated data will serve as a prerequisite for efficient health management and will become a lifetime asset for the individual. An asset one can reference, transfer, reuse, add to, and share throughout a lifetime of healthcare decisions. We are committed to serve as your trusted intermediary.
Megeno was formed by a group of accomplished Luxembourg-based scientists and experienced entrepreneurs from the Munich bio-health sector. Founders, directors, and executive management have extensive experience in creating successful venture backed growth companies.
We aim to identify disease predispositions before they manifest using a broad array of technologies. We apply expert-guided workflows to maintain health.
We personalise our assessment based on your individual biology, lifestyle, and needs and empower you with complete governance over your healthcare data, making it your lifelong asset.
We protect your data as a trusted intermediary, making it accessible only to and for you.
January 22nd 2020
Durch ein Kooperationsprojekt soll im Großherzogtum ein sicherer Speicherdienst für Genomdaten entstehen. Beteiligt sind die Universität Luxemburg und das Start-up Megeno.
January 19th 2020
Megeno S.A. and the University of Luxembourg’s Interdisciplinary Centre for Security, Reliability and Trust (SnT) signed a partnership agreement on the development of user-centred, transparent and secure genome data services.
November 7th 2019
Incubated at University of Luxembourg Incubator, startup Megeno focuses on continuous personalized disease prevention based on the genome. The team believes that a person’s DNA serves as a prerequisite for efficient health management.